23 | VaccinesIBA
05/2024
-
09/2010 |
13 | Malaria VaccinesIBA
01/2022
-
11/2009 |
11 | 1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
05/2024
-
03/2015 |
9 | AntibodiesIBA
01/2021
-
01/2011 |
8 | AntigensIBA
06/2022
-
01/2012 |
7 | Immunoglobulin G (IgG)IBA
01/2022
-
01/2012 |
5 | Proteins (Proteins, Gene)FDA Link
05/2022
-
04/2011 |
5 | Influenza Vaccines (Influenza Vaccine)FDA Link
04/2015
-
06/2013 |
3 | Aluminum Hydroxide (Algeldrate)FDA Link
01/2021
-
01/2019 |
2 | Chloroquine (Aralen)FDA LinkGeneric
05/2024
-
01/2017 |
2 | Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2024
-
11/2021 |
2 | piperaquineIBA
01/2024
-
11/2021 |
2 | artenimol (dihydroartemisinin)IBA
01/2024
-
11/2021 |
2 | pyrimethamine drug combination fanasil (Fansidar)FDA Link
01/2024
-
11/2021 |
2 | Rabies Vaccines (Rabies Vaccine)FDA Link
01/2021
-
01/2011 |
2 | Antimalarials (Antimalarial Agents)IBA
01/2017
-
03/2015 |
2 | Surface Antigens (Surface Antigen)IBA
01/2017
-
04/2016 |
2 | CytokinesIBA
01/2017
-
02/2013 |
2 | DNA (Deoxyribonucleic Acid)IBA
09/2015
-
01/2003 |
2 | OspA proteinIBA
11/2014
-
08/2013 |
2 | RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2014
-
06/2014 |
1 | SARS-CoV-2 spike proteinIBA
12/2022 |
1 | Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2022 |
1 | Warfarin (Coumadin)FDA LinkGeneric
12/2022 |
1 | Merozoite Surface Protein 1 (MSA1)IBA
06/2022 |
1 | Herpes Zoster VaccineIBA
01/2022 |
1 | Immunoglobulins (Immunoglobulin)IBA
01/2022 |
1 | Hydroxychloroquine (Plaquenil)FDA LinkGeneric
05/2021 |
1 | Ferritins (Ferritin)IBA
01/2021 |
1 | Troponin IIBA
01/2021 |
1 | fibrin fragment D (D-dimer)IBA
01/2021 |
1 | Recombinant ProteinsIBA
01/2021 |
1 | Interleukin-6 (Interleukin 6)IBA
01/2021 |
1 | Biomarkers (Surrogate Marker)IBA
01/2021 |
1 | SaponinsIBA
07/2020 |
1 | Ivermectin (Mectizan)FDA Link
01/2020 |
1 | Calcitriol Receptors (Calcitriol Receptor)IBA
10/2019 |
1 | EmulsionsIBA
10/2019 |
1 | saponin QA-21V1 (QS21)IBA
10/2019 |
1 | LipidsIBA
10/2019 |
1 | varicella-zoster virus glycoprotein EIBA
01/2018 |
1 | Hemoglobins (Hemoglobin)IBA
01/2018 |
1 | AS01B adjuvantIBA
01/2018 |
1 | Subunit VaccinesIBA
01/2018 |
1 | Dengue VaccinesIBA
01/2018 |
1 | Antihypertensive Agents (Antihypertensives)IBA
03/2017 |
1 | EnzymesIBA
03/2017 |
1 | Mefloquine (Lariam)FDA LinkGeneric
01/2017 |
1 | aluminum sulfate (alum)IBA
01/2016 |
1 | 18S Ribosomal RNAIBA
09/2015 |
1 | Hemagglutinins (Hemagglutinin)IBA
04/2015 |
1 | cyclo(Arg-Pro) (CI 4)IBA
08/2013 |
1 | RNA (Ribonucleic Acid)IBA
06/2013 |
1 | Broadly Neutralizing AntibodiesIBA
02/2013 |
1 | Glycoproteins (Glycoprotein)IBA
02/2013 |
1 | InterleukinsIBA
02/2013 |
1 | 2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA
02/2013 |
1 | Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
02/2013 |
1 | Ciliary Neurotrophic Factor (CNTF)IBA
02/2013 |
1 | Immunoglobulin E (IgE)IBA
01/2012 |
1 | Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2012 |
1 | Complement System Proteins (Complement)IBA
11/2009 |
1 | Lymphotoxin-betaIBA
01/2003 |